Skip to main content
Federal Lobbying Data · Senate LDA Filings · Updated Quarterly
LobbySpend

Allergan plc

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
57/100
Moderate Influence
$7.9M
Total Lobby Spend
4
Policy Issues
5
Lobbyists
2
Revolving Door

Allergan plc reported $7.9 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of Defense
Dept of the Treasury
Office of Management & Budget
Dept of Health & Human Services
Dept of Transportation

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecWilliams & Jensen
HCRPHAMED+1
4$370K
2024 Jul-SepArnold & Porter
PHAMEDHCR
4$412K
2024 Apr-JunHolland & Knight
GOVHCR
4$445K
2024 Jan-MarCassidy & Associates
HCRGOV
3$448K
2023 Oct-DecVenable LLP
PHAMEDGOV+1
1$369K
2023 Jul-SepFranklin Square Group
HCRGOVPHA
4$515K
2023 Apr-JunFierce Government Relations
MEDGOV
2$444K
2023 Jan-MarJones Day
GOVHCR
1$434K

Allergan plc Lobbying FAQ

Allergan plc has spent $7.9M on federal lobbying across 4 policy areas. This includes spending on registered lobbyists and direct government contacts.

Allergan plc lobbies on 4 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Allergan plc has an Influence Score of 57/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Allergan plc employs 5 registered lobbyists, of whom 2 have revolving door connections, meaning they previously held government positions before becoming lobbyists.

Allergan plc has contacted 5 government entities as part of their lobbying activities, including Dept of Defense, Dept of the Treasury, Office of Management & Budget.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.